AtriCure, Inc. (ATRC) Misses Q4 Loss Views by 2c/Share; Guides FY13 Revs
AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.12), $0.02 worse than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
